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Molecular Medicine
Tbx5 Is Required for Avian and Mammalian Epicardial
Formation and Coronary Vasculogenesis
Nata Y.S.-G. Diman, Gabriel Brooks, Boudewijn P.T. Kruithof, Olivier Elemento,
J.G. Seidman, Christine E. Seidman, Craig T. Basson, Cathy J. Hatcher

Rationale: Holt–Oram syndrome is an autosomal dominant heart-hand syndrome caused by mutations in the
TBX5 gene. Overexpression of Tbx5 in the chick proepicardial organ impaired coronary blood vessel formation.
However, the potential activity of Tbx5 in the epicardium itself, and the role of Tbx5 in mammalian coronary
vasculogenesis, remains largely unknown.
Objective: To evaluate the consequences of altered Tbx5 gene dosage during proepicardial organ and epicardial
development in the embryonic chick and mouse.
Methods and Results: Retroviral-mediated knockdown or upregulation of Tbx5 expression in the embryonic
chick proepicardial organ and proepicardial-specific deletion of Tbx5 in the embryonic mouse (Tbx5epi-/) impaired
normal proepicardial organ cell development, inhibited epicardial and coronary blood vessel formation, and
altered developmental gene expression. The generation of epicardial-derived cells and their migration into the
myocardium were impaired between embryonic day (E) 13.5 to 15.5 in mutant hearts because of delayed epicardial
attachment to the myocardium and subepicardial accumulation of epicardial-derived cells. This caused defective
coronary vasculogenesis associated with impaired vascular smooth muscle cell recruitment and reduced invasion
of cardiac fibroblasts and endothelial cells into myocardium. In contrast to wild-type hearts that exhibited an
elaborate ventricular vascular network, Tbx5epi-/- hearts displayed a marked decrease in vascular density that was
associated with myocardial hypoxia as exemplified by hypoxia inducible factor-1α upregulation and increased
binding of hypoxyprobe-1. Tbx5epi-/- mice with such myocardial hypoxia exhibited reduced exercise capacity when
compared with wild-type mice.
Conclusions: Our findings support a conserved Tbx5 dose-dependent requirement for both proepicardial
and epicardial progenitor cell development in chick and in mouse coronary vascular formation.
(Circ Res. 2014;115:834-844.)
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picardial formation and coronary vasculogenesis are
highly regulated processes that involve a series of spatiotemporally regulated molecular and cellular events.1,2 These
processes begin with formation of the proepicardial organ
(PEO)/proepicardium and involve epicardial-derived cell
(EPDC) transition. The PEO is located at the venous pole of
the heart and is part of the septum transversum. This transitory
structure is comprised of mesothelial cells morphologically
visible in the mouse between embryonic day (E) 9 and 9.5.1 At
E10.5, the epicardium is formed and fully matured by E11.5. A
subset of epicardial cells undergoes epithelial–mesenchymal
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Tbx5

transition (EMT) to generate EPDCs that delaminate and
populate the subepicardial space and further migrate into the
underlying myocardium.1,3 Here, they differentiate into the
cellular elements of coronary blood vessels (ie, endothelial
cells, smooth muscle cells [SMC], and cardiac fibroblasts).
Subepicardial endothelial cells contribute to both coronary
arteries and veins.4 The sinus venosus and endocardium also
contribute coronary endothelial cells to form the developing
coronary arteries.5,6 Subsequently, these cellular components
coalesce and form the primitive vascular plexus that ultimately remodels to form the coronary blood vessels. Using various
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Nonstandard Abbreviations and Acronyms
cTbx5
cTbx5As-CXL
CXIZ
E
ECM
EMT
EPDCs
HH
HOS
mTbx5
PEO
SMC
SM22α
Tbx
Tbx5epi-/Wt1

chick Tbx5
CXL retrovirus encoding antisense chick Tbx5
control retrovirus encoding β-galactosidase
embryonic day
extracellular matrix
epithelial–mesenchymal transformation
epicardial-derived cells
Hamburger-Hamilton
Holt–Oram syndrome
mouse Tbx5
proepicardial organ
smooth muscle cell
smooth muscle 22 α (transgelin)
T-box
Tbx5lox/lox;Wt1-Cre
Wilm’s tumor 1

mouse models with Cre-recombinase expressed in epicardial
and/or EPDCs, investigators have demonstrated multiple contributions of EPDCs to coronary smooth muscle, coronary
endothelium, the interstitial fibroblast population, and the
atrioventricular junctional myocardium.1,2,7–10
The epicardium plays a pivotal role in cardiac development
because paracrine-mediated secretion of epicardial factors,
such as Wnts, erythropoietin, fibroblast growth factors, and
retinoids, are important for embryonic compact myocardial
growth1,2 and can be reactivated during cardiac injury and repair.11 PEO ablation/blockade that perturbs or delays epicardial formation and genetic ablation of various genes expressed
in the proepicardium or myocardium leads to abnormal coronary vasculogenesis, myocardial defects, and potential embryonic lethality.1,2
T-box transcription factor genes, including Tbx5 and
Tbx18, are expressed in the PEO or septum transversum.1,12–15
We previously showed that the manipulation of Tbx5 gene
dosage in the chick PEO affects proepicardial cell migration
and can impair avian coronary vasculogenesis.16 However,
these studies did not address the potential activity of Tbx5
in the epicardium itself. The mechanisms by which Tbx5
controls mammalian coronary vasculogenesis remain largely
unknown, and the relevance of avian signaling to mammalian
ontogeny was not tested. Holt–Oram syndrome (HOS) is a
human inherited disorder caused by mutations in TBX5 and
manifests as congenital cardiac septation and conduction defects in the setting of limb deformities.17,18 Some patients with
HOS also exhibit left pericardium agenesis and anomalous
coronary arteries along with ventricular septal defects19,20
consistent with a role for TBX5 in epicardial/pericardial and
myocardial development. Early embryonic lethality resulting
from germline inactivation of Tbx5 in the mouse has precluded further investigation of the function of Tbx5 in later stages
of cardiac development, including epicardial formation and
coronary vasculogenesis.21
We have now developed strategies to investigate epicardial activity of Tbx5 in the chick, and we have generated

conditional mutant mice with Tbx5 deletion from the proepicardial and epicardial derivatives. We show that Tbx5 expression in the proepicardium/PEO and epicardium is required for
normal development of proepicardium/PEO cells, as well as
proper epicardial formation and maturation. Tbx5 deficiency
delays epicardial cell attachment to the myocardium, impairs
production of EPDCs and their migration into the myocardium, and results in abnormal coronary vasculogenesis and
murine ischemic cardiomyopathy. Our findings demonstrate
that Tbx5 is required both for proepicardial and for epicardial
development in avian and in mammalian hearts and for establishment of the coronary vasculature.

Methods

Tbx5lox/lox 21 and Wilm’s tumor 1 (Wt1)-Cre8,22 mice have been described. Generation of retrovirus and in ovo retroviral injection was
performed as previously described16 with the exception of epicardial
infection that was accomplished by retroviral injection into the pericardial space of the embryonic chick.
An expanded Methods section, including all experimental procedures, is available in the Online Data Supplement.

Results
Tbx5 Expression in Chick and Mouse PEO and
Derivatives
Although Tbx5 myocardial and endocardial expressions have
been previously described during cardiogenesis,16,23,24 the detailed spatiotemporal patterns of chick and mouse Tbx5 expression in the PEO/proepicardium and epicardium have not
been well defined. In situ hybridization in chick embryos
revealed heterogeneous staining in the PEO at Hamburger–
Hamilton (HH) stage 16 or E3 (Online Figure IA and IE). By
HH22 (E4), chick Tbx5 (cTbx5) remained detectable in the
PEO remnant and in migrating proepicardial cells contacting
the myocardium. By HH26 (E5), cTbx5 was evident in the
newly formed epicardium (Online Figure IB and IF). A similar expression pattern for mouse Tbx5 (mTbx5) was observed
by in situ hybridization at the corresponding developmental
stages of E9.5 (Online Figure IC and IG) and E10.5 in the
mouse (Online Figure ID and IH). Immunostaining for mTbx5
protein expression showed a spatiotemporal pattern similar to
that observed with our in situ hybridization data. At E9.5, nuclear expression of mTbx5 protein was evident in the murine
proepicardium in a heterogeneous pattern (Online Figure II
and IL). At E10.5, mTbx5 protein expression was evident in
the nascent epicardium and pericardium (Online Figure IJ).
Whereas some epicardial cells were Tbx5-negative (online
Figure IM), all epicardial cells expressed Wt1 (Online Figure
IN). Tbx5 expression was decreased in the epicardial cells by
E11.5 (Online Figure IK and IO), but persists into adulthood
as previously shown.25 Thus, these analyses support spatial
and temporal restriction of Tbx5 expression in the embryonic
chick and murine PEO/proepicardium and epicardium.

Tbx5 Contributes to In Vitro and In Vivo
Proepicardial Cell Development
We previously demonstrated that Tbx5 overexpression disrupts chick proepicardial cell migration in vitro.16 To determine the requirement for cTbx5 in epicardial formation
and coronary vasculogenesis, we used retroviral-mediated
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transgenesis with an antisense (cTbx5As-CXL) construct
(Online Figure IIA) to knock down cTbx5 expression in
cultured PEO explants in a manner similar to our previous
TBX5 overexpression studies.16 Retroviral-mediated cTbx5
knockdown produced a 45% reduction of in vitro migration
of proepicardial cells to the periphery of PEO explants compared with control CXL PEOs (Online Figure IIIA–IIIC).
This demonstrated that cTbx5 expression is required for in
vitro chick proepicardial cell migration.
To confirm that this requirement for cTbx5 was preserved
in PEO cell migration and coronary vasculogenesis in vivo,
we injected either control CXL26 or cTbx5As-CXL retrovirus
into chick PEOs in ovo at HH17-18 (E3; Online Figure IIA).
By 8 hours after injection, we observed transgene expression
in the PEO as shown by X-gal staining for β-galactosidase
activity for both retroviruses (Figure 1A and 1E). Twentyfour hours after PEO injection with the control CXL virus,
β-galactosidase–positive cells were visible on the surface of
the heart (Figure 1B). However, embryos that received PEO
injections of cTbx5As-CXL to knock down Tbx5 expression
exhibited only scant β-galactosidase–positive cells on the surface of the heart (Figure 1F). By 12 days after injection, E15
CXL-infected embryos (15/15 embryos) displayed prominent
β-galactosidase–positive staining in the coronary vasculature
(Figure 1C and 1D). Hearts from E15 embryos infected with
cTbx5As-CXL did not show any evidence of β-galactosidase
staining in the coronary vessels (0/13 embryos; Figure 1G).
All hearts exhibited minimal levels of myocardial staining at
24 hours to 12 days after injection because of slight retroviral leakage into the myocardium during the initial pressure
injection of the retrovirus as evidenced by β-galactosidase
staining of myocardial cells in E15 hearts (Figure 1C and 1G).
This staining confirmed the infectivity of all viruses. Thus,

maintenance of normal Tbx5 expression in the chick PEO is
required for proper development of the epicardium and coronary vasculature.

Tbx5 Contributes to Chick Epicardial Cell Fate and
Coronary Artery Development
To determine whether Tbx5 activity during coronary vasculogenesis is required in the epicardium independent of
its activity in the PEO, we used retroviral-mediated transgenesis to augment or knock down Tbx5 in the nascent epicardium in vivo directly. We microinjected either the same
retroviruses as described above or control retrovirus encoding
β-galactosidase (CXIZ) and TBX5-CXIZ retrovirus27 (Online
Figure IIA) into the pericardial space (Online Figure IIB) at
later stages of development (E4) when the epicardium had
largely already formed. This produces transgenesis of the
nascent epicardium (Figure 1I–1P). Because epicardium formation was not fully completed at this stage, areas of naked
myocardium were exposed to viruses with this strategy, and
the presence of infected myocardium in each embryo provided a positive control for viral infectivity. β-galactosidase–
positive cells demonstrated infectivity of the epicardium at
8 (Figure 1I) and 24 hours (Figure 1J) after injection for all
viruses. By 11 days after injection, β-galactosidase–positive
cells were visible in the coronary blood vessels of most E15
CXL- and CXIZ-injected control embryos (21/23 CXL embryos; Figure 1K and 1L; 22/23 CXIZ embryos [not shown]).
Altered embryonic epicardial Tbx5 expression (knockdown
with cTbx5As-CXL [1/15 embryos]; Figure 1M and 1N) or
overexpression with TBX5-CXIZ (0/18 embryos; Figure 1O
and 1P) inhibited incorporation of infected cells into the
coronary vasculature. These hearts displayed only sparse and
patchy β-galactosidase–positive cells in the myocardium and

Figure 1. Knockdown and overexpression
of Tbx5 affects proepicardial organ (PEO)
cell development. A–P, Retroviral-mediated
manipulation of Tbx5 gene dosage in ovo.
β-galactosidase activity in whole mount hearts
at 8 hours (A, E, I), 24 hours (B, F, J), and at E15
(C, D, G, H, K–P) after either in ovo PEO retroviral
microinjection at HH16 with control CXL (A–D)
and cTbx5As-CXL (E–H) retroviruses or in ovo
epicardial infection at HH23 with control CXL (I–L),
cTbx5As-CXL (M and N) and TBX5-CXIZ (O and
P) retroviruses. Arrows indicate β-galactosidase–
positive PEO cells (A and E), epicardial cells (H),
and also coronary vessels with (D and L) or without
(N and P) β-galactosidase activity. Scale bars,
100 μm (A–P).
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epicardium (Figure 1N and 1P). Thus, maintenance of normal Tbx5 dosage in the epicardium is required for its proper
maturation and the subsequent incorporation of EPDCs into
coronary blood vessels.
To investigate cellular mechanisms underlying impaired
epicardial cell development, we examined the effect of cTbx5
augmentation on in vitro PEO cell behavior. We previously
demonstrated that in vitro TBX5 overexpression in PEO explants impaired migration of proepicardial cells out of these
TBX5-CXIZ–infected PEO explants but did not affect PEO
cell proliferation.16 In addition to our previous observations, we now detect some apoptotic migratory proepicardial
cells outside of the PEO explants (Online Figure IIID–IIIF).
Apoptosis was not observed in control CXIZ-infected migratory proepicardial cells. Thus, in vitro augmentation of proepicardial cTbx5 not only impaired migration of proepicardial
cells, but also caused apoptosis in some migratory proepicardial cells.

Epicardial Inactivation of Murine Tbx5 Affects
Formation and Maturation of the Epicardium and
Migration of EPDCs
In the mouse, ubiquitous deletion of mTbx5 caused embryonic
lethality by E10.5 that previously precluded analysis of coronary vasculogenesis.21 We circumvented this barrier by conditional tissue-specific ablation of Tbx5 in the proepicardium
and its derivatives. We crossed C57Bl/6 female Tbx5 conditional knockout mice (Tbx5lox/lox)21 with C57Bl/6 male Wt1Cre driver mice that express Cre-recombinase in proepicardial
and epicardial cells.8,22 Male progeny (Tbx5epi+/-) exhibiting
excision of 1 Tbx5 floxed allele and carrying the Cre transgene were crossed against female Tbx5lox/lox to generate mice
with 2 floxed alleles excised in proepicardial cells, and hereafter referred to as Tbx5lox/lox;Wt1-Cre (Tbx5epi-/-). We confirmed
Cre-mediated deletion of Tbx5 and diminished Tbx5 mRNA
expression in proepicardial cells of Tbx5epi-/- versus wild-type
control mice (Online Figure IVA–IVE). Tbx5epi-/- mice were
born at significantly reduced Mendelian ratios compared with
control mice (P=0.03; Online Figure IVF).
We analyzed Tbx5epi-/- embryos at various developmental
stages to gain insight into the cause of lethality. Examination
of whole mount and sectioned hearts from E9.5 wild-type
and mutant mice revealed that both wild-type (Figure 2A and
2B) and Tbx5epi-/- (Figure 2D and 2E) embryos form a proepicardium and express the proepicardial and epicardial cell
marker, Wt1, in the proepicardium at E9.5 (Figure 2C and
2F). Although proepicardium specification appeared normal
in Tbx5epi-/- embryos, mutant proepicardiums (Figure 2D–2F)
often appeared smaller relative to wild-type proepicardiums
(Figure 2A–2C). Analyses of in vivo cell behavior by Ki-67
immunostaining (Online Figure VA–VD) and terminal deoxynucleotidyl transferase dUTP nick end labeling (not shown)
revealed unmodified rates of proliferation (Online Figure
VE), and no evidence of increased apoptosis, respectively, in
Tbx5epi-/- proepicardial cells was observed. Furthermore, our
examination of proepicardial cell polarity in these embryos did
not reveal altered expression or localization of apical (PAR3,
ezrin), basolateral (α4-integrin), and cell–cell junctional (ZO1) markers28 between wild-type and mutant proepicardiums at

Figure 2. Phenotypic characterization of E9.5 Tbx5epi-/embryos. A–F, Representative images of whole mount and
sectioned E9.5 embryos. Whole mount wild-type (A) and Tbx5epi-/mutant (D) embryos. Hematoxylin and eosin (H&E)–stained
sections of wild-type (B) and Tbx5epi-/- mutant (E) embryos.
Immunofluorescent detection of Wt1 (pink) in sectioned wildtype (C) and Tbx5epi-/- (F) hearts. Nuclei counterstained with
4,6-diamidino-2-phenylindole (blue). Scale bars, 500 μm (A and
D) and 100 μm (B and E). Arrowheads (A and D) and asterisks
(B, C, E, F) indicate proepicardium outlined by dashes. G–J,
H&E-stained sections of E11.5 wild-type (G and H) and Tbx5epi-/(I and J) hearts. Arrowheads indicate epicardium. Scale bar, 200
μm (G–J). A indicates atrium; and V, ventricle.

E9.5. These data indicated that Tbx5 deficiency did not alter
proepicardial cell proliferation, apoptosis, or polarity.
The epicardial cell layer, as indicated by Wt1-positive cells,
began to form on the myocardial surface of E10.5 wild-type
and Tbx5epi-/- hearts (not shown). Although a smooth-surfaced
epicardium was observed in E11.5 wild-type hearts (Figure 2G
and 2H), the epicardium in Tbx5epi-/- hearts appeared irregular and ruffled with focal regions that were unattached to the
myocardium (Figures 2I and 2J). However, Wt1-positive epicardial cells were attached to the myocardium in both wildtype (Figure 3A) and Tbx5epi-/-(Figure 3D) hearts by E12.5.
These data indicate that deletion of Tbx5 delayed adhesion
of the epicardial cell layer to the myocardium, and Tbx5 is
important for proper structural formation of the epicardium.
Within the subepicardial space of E13.5 wild-type and mutant
hearts, Wt1-positive epicardial cells began to delaminate and
EPDCs began invading the compact myocardium (Figure 3B
and 3E). Nonetheless, fewer Wt1-positive EPDCs invaded the
compact myocardium of E13.5 mutant hearts (Figure 3E). We
observed focal accumulation of Wt1-positive cells in the subepicardium of E14.5 mutant embryos (Figure 3F) when compared with wild-type littermates (Figure 3C). Quantification
of these cells in the compact myocardium of E14.5 mice revealed a 48.5% reduction in Wt1-positive EPDCs in Tbx5epi-/hearts versus wild-types (Figure 3G). Thus, Tbx5 is important
for proper EPDC migration.
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Figure 3. Altered migration of
epicardial-derived cells into the
myocardium of Tbx5epi-/- hearts. A–F,
Immunohistochemical detection of Wt1positive epicardial cells (brown) in wildtype (A–C) and Tbx5epi-/- (D–F) sectioned
embryonic hearts at E12.5 (A and D),
E13.5 (B and F), and E14.5 (C and F).
Nuclei counterstained with hematoxylin
(blue). Scale bars, 100 μm. Arrowheads
denote Wt1-positive cells in the ventricle
and epicardium. G, Quantification of Wt1positive cells in the compact myocardium
of E14.5 wild-type (black bar; n=4) and
Tbx5epi-/- (white bar; n=4) hearts. Data
represented as mean±SEM. *P<0.05 vs
wild-type. V indicates ventricle.

Migration of EPDCs into the myocardium occurs in a patterned manner that involves several mechanisms, including epicardial cell proliferation, survival,29,30 and EMT.31,32
Despite the absence of altered proepicardial cell proliferation
in E9.5 Tbx5epi-/- embryos, we observed a 42% reduction in
Ki-67–positive proliferating epicardial cells in E12.5 Tbx5epi-/embryos (Figure 4E and 4I) when compared with wild-types
(Figure 4A and 4I). Examination of these hearts for potential

EMT defects induced by proepicardial-specific deletion of
Tbx5 did not reveal significant changes in the expression of the
EMT markers Slug, Snail, and E-cadherin in E14.5 mutant versus wild-type embryos (not shown). These data demonstrate
that proepicardial loss of Tbx5 produces developmental defects
in the epicardium and EPDCs that may be precipitated by delayed epicardial cell adhesion to the myocardium and partially
attributed to a reduction in epicardial cell proliferaton.

Figure 4. Altered cell behavior, thinned myocardium, and structural defects in Tbx5epi-/- hearts. A–H, Representative images of
sectioned hearts. Immunofluorescent detection of Ki-67 (green) and cardiac actin (red) in E12.5 wild-type (A) and Tbx5epi-/- (E) hearts.
Nuclei counterstained with 4,6-diamidino-2-phenylindole. Hematoxylin and eosin (H+E)–stained sections in E12.5 (B, C, F, G) or E15.5
(D and H) wild-type (A–D) and Tbx5epi-/- (E–H) hearts. Myocardial wall thickness indicated by brackets. Arrowhead indicates epicardium
(A and E) or ventricular septal defect (H). I, Quantification of Ki-67–positive epicardial cells in wild-type (black bar; n=4) and Tbx5epi-/(white bar; n=4) hearts. Scale bars, 100 μm (A, C, E, G) and 500 μm (B, F, D, H). Data represented as mean+SEM. *P<0.05 vs wild-type.
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Structural Defects and Impaired Cardiac Growth in
Tbx5epi-/- Mice
We did not observe gross morphological differences in whole
mount embryos or hearts from E12.5 wild-type and Tbx5epi-/mice. Normal formation of the compact myocardium was
observed in hematoxylin and eosin–stained wild-type E12.5
hearts (Figure 4B and 4C). However, we observed a thinned
compact myocardium in E12.5 Tbx5epi-/- mice (Figure 4F and
4G) in comparison with wild-type littermates. A comparison of
Ki-67–positive cardiomyocytes in E12.5 wild-type versus mutant mouse hearts revealed a 48% reduction in cardiomyocyte
proliferation in Tbx5epi-/- hearts when compared with wild-type
hearts (not shown). Terminal deoxynucleotidyl transferase
dUTP nick end labeling assays of sectioned hearts did not
reveal myocardial apoptosis in the hearts of E12.5 wild-type
or Tbx5epi-/- embryos. However, myocardial apoptosis was observed in E14.5 mutant hearts when compared with wild-types
(not shown). In contrast to wild-type hearts (Figure 4D), muscular and membranous ventricular septal defects were seen
in 15% of E15.5 Tbx5epi-/- embryos (Figure 4H). Collectively,
these myocardial defects may result from both a decrease in
myocardial cell proliferation and the onset of cardiomyocyte
apoptosis secondary to impaired epicardial formation and
EPDC development in Tbx5epi-/- embryos.

Epicardial Inactivation of Tbx5 Affects
Development of the EPDCs and Coronary
Vasculogenesis
Gross inspection of E15.5 wild-type and Tbx5epi-/- mice revealed areas of peripheral hemorrhage in mutant embryos
(Online Figure VIE) that was not observed in wild-type littermates (Online Figure VIA). Overall cardiac patterning was
similar in both wild-type and mutant mice, but ventricular
chamber size appeared to be reduced in Tbx5epi-/- versus wildtype embryos. In contrast to E15.5 wild-type hearts (Online
Figure VIB), Tbx5epi-/- hearts exhibited punctate areas of hemorrhaging (Online Figure VIF). Histology revealed abnormal
vascular structures in mutant hearts. As opposed to E15.5
wild-type hearts (Online Figure VIC), Tbx5epi-/- hearts exhibited epicardial cyst-like structures lined by delaminated epicardium that were filled with erythrocytes (Online Figure VIG).
Platelet endothelial cell adhesion molecule-1 immunostaining
revealed a subepicardial accumulation of vessels in mutant
hearts (Online Figure VIH) compared with wild-types (Online
Figure VID). Together, these data are indicative of a coronary
vascular defect in Tbx5epi-/- hearts.
Given that EPDCs differentiate into SMCs, cardiac fibroblasts, and endothelial cells,1,2,7,8 we determined the effects of
proepicardial-specific deletion of Tbx5 on these cell populations. Histological analysis of E17.5 wild-type and Tbx5epi-/hearts revealed nests of multiple contiguous subepicardial
vessel-like structures that did not penetrate the myocardium
of mutant hearts (Figure 5E) in contrast to wild-type hearts
(Figure 5A). We determined that SMC recruitment to nascent
coronary vessels was affected in Tbx5epi-/- hearts via immunohistochemical analysis for SMC-specific protein (SM22α). SMCs
formed a continuous layer surrounding the coronary vessels of
E17.5 wild-type hearts (Figure 5B), whereas the SMC layer was
either completely lost or discontinuous throughout the coronary

vessels of Tbx5epi-/- hearts (Figure 5F). Immunostaining for periostin, a marker of the noncardiomyocyte lineage that is enriched
in cardiac fibroblasts, revealed a reduced fibroblast invasion of
the cardiac interstitium in E17.5 Tbx5epi-/- hearts (Figure 5G)
when compared with wild-types (Figure 5C). Platelet endothelial cell adhesion molecule-1 (CD31) immunostaining revealed an elaborate ventricular capillary network in wild-type
(Figure 5D) and Tbx5epi-/- hearts (Figure 5H). However, subsequent vessel quantification revealed a 45% reduction in platelet
endothelial cell adhesion molecule-1–positive capillary density
in Tbx5epi-/- hearts compared with wild-type hearts (Figure 5M).
Together, these results suggest that a partial defect occurred
during coronary vascular maturation in Tbx5epi-/- hearts that affected SMC recruitment and caused reductions in formation of
endothelial cells and other noncardiomyocytes that may include
cardiac fibroblasts.
We sought to determine the physiological manifestations
of these vascular developmental anomalies. In fact, we observed hypoxia in Tbx5epi-/- mice. Compared with wild-type
hearts (Figure 5I and 5J), E18.5 Tbx5epi-/- hearts displayed
increased immunoreactivity for hypoxia inducible factor-1α
(Figure 5K), as well as increased binding of hypoxyprobe-1
(pimonidazole hydrochloride; Figure 5L), respectively.
Hypoxyprobe-1 forms protein adducts in cells with a
PO2<10 mm Hg. To determine the physiological consequences
of this myocardial relative hypoxic state, we evaluated the maximal exercise capacity of Tbx5epi-/- mice. Twelve- to 16-weekold Tbx5epi-/- mice were subjected to graded treadmill exercise
testing.33 In contrast to wild-type mice, Tbx5epi-/- mice exhibited
a significantly reduced maximal exercise tolerance (Figure 5N).

Transcriptome Analysis of Wild-Type and Tbx5epi-/Mouse Hearts
To gain insight into Tbx5-dependent molecular pathways
involved in epicardial and EPDC development during coronary vasculogenesis, we characterized the transcriptome
of E11.5 wild-type and Tbx5epi-/- hearts. Expression of 57
genes was dysregulated in Tbx5epi-/- hearts (P<0.05). Among
these dysregulated genes, 91.2% were downregulated and
8.8% were upregulated in Tbx5epi-/- versus wild-type hearts
(Figure 6A). Gene ontology analysis of significantly downregulated transcripts in Tbx5epi-/- mouse hearts revealed
dysregulation of genes involved in vitamin A biosynthesis,
cell adhesion, enhancer binding, RNA polymerase II transcriptional activity, and developmental growth (Figure 6B).
Genes encoding these biological functions, which correlate
to retinoic acid signaling, gene transcription, development,
and cell–cell interactions, contribute to epicardial and EPDC
development.1,2,29,34–36 We previously observed focal regions
of irregular, ruffled epicardium that were unattached to the
myocardium in E11.5 Tbx5epi-/- hearts, but became attached
by E12.5. Because changes in expression of cell adhesion and
extracellular matrix (ECM) proteins could contribute to such
abnormal epicardial integrity, we used quantitative reverse
transcriptase-polymerase chain reaction to validate mRNA
expression of the Ajap1, Frem3, and Reln genes encoding
these cell adhesion and ECM proteins.37–39 Expression of
these genes was significantly decreased in epicardial cells and
EPDCs of E11.5 mutant versus wild-type hearts (Figure 6C)
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Figure 5. Defective epicardial-derived cell development and cardiac ischemia in Tbx5epi-/- mouse hearts. A–H, Representative
images of Hematoxylin and eosin (H+E)–stained (A and E) and immunofluorescently stained sections of E17.5 wild-type (A–D) and
Tbx5epi-/- (E–H) sectioned hearts. Immunofluorescent detection of the smooth muscle cell–specific protein (SM22α; B and F, green),
periostin (C and G, green), cardiac actin (C and G, red), and platelet endothelial cell adhesion molecule-1 (PECAM-1)/CD31 (D and
H, red). Nuclei couterstained with 4,6-diamidino-2-phenylindole (DAPI; B and F, blue). I–L, hypoxia inducible factor-1α (HIF1α)
immunostaining (dark brown) of E18.5 wild-type (I) and Tbx5epi-/- (K) sectioned hearts. Nuclei counterstained with hematoxylin (blue).
Hypoxyprobe-1 binding (green) on sectioned E18.5 wild-type (J) and Tbx5epi-/- mutant (L) hearts. Nuclei counterstained with DAPI (blue).
M, Quantification of PECAM-1–positive vessels/high-powered field (HPF) in E17.5 wild-type (black bar; n=4) and Tbx5epi-/- (white bar;
n=4) hearts. Data represent mean+SEM. *P<0.05 vs wild-type. N, Absolute maximum exercise tolerance quantified in 12- to 16-weekold adult wild-type (black bar; n= 6) and Tbx5epi-/- (white bar; n=10) mice. Data represent mean±SEM; *P<0.05 vs wild-type. Scale bars,
100 μm (A–L).

and this may contribute to the delayed epicardial cell attachment to the myocardium in these hearts.

Discussion
In this study, we demonstrate a conserved requirement for
Tbx5 in avian and mammalian proepicardial development, as
well as epicardial and coronary vascular formation and maturation. We show that Tbx5 displays a dynamic expression pattern
in embryonic proepicardial cell lineages and regulates development of chick and mouse epicardial and coronary vascular

progenitor cells from the PEO and epicardium, respectively.
Moreover, genetically engineered loss of Tbx5 in the mouse
proepicardium results in defective epicardial formation because of delayed epicardial cell adhesion to the myocardium
and altered developmental gene expression. We believe that
this consequently leads to impaired EPDC production and invasion into the myocardium, compromised establishment of
the coronary vasculature, decreased myocardial growth and
myocardial hypoxia, and reduced maximal exercise tolerance
in Tbx5epi-/- mice. We conclude that Tbx5 is indispensable for
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Figure 6. Altered cardiac gene expression with proepicardial-specific deletion of mouse Tbx5. A, Representation of the percentage
of genes upregulated (red) or downregulated (blue) in hearts of E11.5 Tbx5epi-/- vs wild-type mice. B, Gene ontology analysis of
significantly enriched biological processes displayed as –log base 10 (p value). C. Quantitative reverse transcriptase-polymerase chain
reaction analysis of Ajap-1, Frem3, and Reln gene expression in epicardial cells and EPDCs of E11.5 wild-type (black bar; n=4) and
Tbx5epi-/- hearts (white bar; n=4). Data represent mean±SEM, *P<0.05 vs wild-type.

normal epicardial formation and coronary vasculogenesis during embryogenesis, and this requirement may be reflected in
the pericardial agenesis and anomalous coronary arteries seen
in human patients with HOS and defective TBX5.19,20
Loss of murine Tbx5 in the proepicardium did not prevent
proepicardial cell specification and formation in Tbx5epi-/mouse embryos as exhibited in zebrafish with mutant Tbx5.40
The genetically heterogeneous nature of the proepicardium
was recently demonstrated to have molecularly distinct expression domains7 and our expression analyses similarly suggest
that Tbx5 expression is also heterogeneous throughout the developing proepicardium and epicardium. This may explain the
normal specification and development of proepicardial cells
in Tbx5epi-/- embryos. We will further explore this heterogeneity of Tbx5 expression in the proepicardium in future studies.
Furthermore, we cannot exclude that other T-box transcription
factors expressed in the proepicardium and EPDCs, such as
Tbx1815, may partially compensate for the Tbx5 deficiency.
Although proepicardial development is molecularly conserved across species,40 we speculate that minor differences
in Tbx5 expression and function occur during proepicardial
development across species. This was exemplified by the lack
of a functionally conserved requirement for Tbx5 between our
embryonic chicks and mice in regulating proepicardial cell
apoptosis. Although we observed some apoptotic migratory
proepicardial cells outside of the TBX5-CXIZ–infected chick

PEO explants, we did not observe apoptotic proepicardial cells
in Tbx5epi-/- mouse embryos. We speculate that apoptosis is an
epiphenomenon of altered chick Tbx5 gene dose that reflects
the untimely fate of proepicardial cells with augmented cell
migratory behavior. This may partially explain the reduced incorporation of EPDCs into the coronary vessels of hearts from
E15 cTbx5As-CXL or TBX5-CXIZ–injected chick embryos.
The epicardial cell layer formed in E11.5 Tbx5epi-/- mice.
However, its structural integrity appeared defective as exhibited by an irregular, ruffled epicardium with focal regions
that delayed attachment to the myocardium until E12.5.
Transcriptome analysis of our E11.5 mouse hearts demonstrated that proepicardium-specific deletion of Tbx5 altered
several biological functions, including cell–cell interactions.
Ajap1, Frem3, and Reln, which encode cell adhesion and ECM
proteins, were among the downregulated genes identified in
our Tbx5epi-/- mouse hearts. Epicardial cell adhesion to the
myocardium is important for EPDC production and delamination into the subepicardial space, invasion into the myocardium and coronary vasculogenesis.1,2,29,34–36 The contribution
of these genes to cardiovascular development is unknown,
but these structural adhesion molecules are known to mediate cell–cell interactions in extracardiac tissues37–39 and, thus,
we have identified novel genes involved in a Tbx5-dependent
pathway of epicardial development. We think that downregulation of these cell adhesion and ECM genes may contribute
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to the delayed epicardial cell attachment to the myocardium
in Tbx5epi-/- hearts. Proper establishment of epicardial structure
provides the foundation for subsequent EPDC development,
delamination into the subepicardial space and myocardial invasion to form coronary vessels. Thus, it is likely that the defective epicardial structure of our Tbx5epi-/- embryonic hearts
precipitated the decrease in EPDC production, impaired
myocardial migration of EPDCs, and also perturbed coronary
vasculogenesis. These findings are reminiscent of the structural and functional defects observed during epicardium and
coronary vascular development of proepicardium-specific
Tbx18-deficient mice, which similarly exhibited an irregular epicardial surface with frequent areas distended from the
myocardium, as well as subepicardial nodules containing
erythroblasts.15 EPDC invasion of the myocardium involves
several mechanisms, including epicardial cell proliferation,
survival,29,30 and EMT.31,32 Although expression of EMT and
apoptotic markers was unaffected by proepicardium-specific
deletion of Tbx5 in our mice, epicardial cell proliferation was
significantly reduced in E12.5 Tbx5epi-/- embryos. Tbx5 has
been previously shown to regulate cell proliferation during
morphogenesis of tissues, including the vertebrate heart.27,41
The diminished epicardial cell proliferation observed in our
mutant mice may underlie the impaired production of EPDCs
given that epicardial cell proliferation is intricately linked to
EPDC invasion of the myocardium.30,42 Thus, we think that
the impaired EPDC development in our Tbx5epi-/- embryos is
a consequence of a suboptimal environment previously established by delayed epicardial cell adhesion to the myocardium
and this is compounded by reduced epicardial cell proliferation. The resultant inability of EPDCs to invade the myocardium is consistent with previous reports of altered deposition
of adhesion molecules during mammalian cardiogenesis
that hindered EPDC migration into the ventricular myocardium.29,34,43,44 Altogether, these data indicate that Tbx5 expression is critical for establishing normal epicardial structure and
subsequent EPDC production.
EPDCs contribute to the formation of SMCs, endothelial
cells, and cardiac fibroblasts in avian and murine hearts during
coronary vasculogenesis.1,2,7,45 In fetal Tbx5epi-/- mouse hearts,
we observed impaired SMC recruitment and a reduction in
endothelial cells and cardiac fibroblasts. Our data demonstrate
that impaired development of these lineages subsequently
leads to abnormal coronary vasculogenesis in Tbx5epi-/- hearts.
Further analysis will need to be performed to determine whether Tbx5 acts directly or indirectly to influence differentiation
of these lineages. However, we speculate that delayed epicardial cell attachment to the myocardium precipitates a cascade
of events that lead to abnormal coronary vasculogenesis in
Tbx5epi-/- hearts. Our data collectively support a model in which
proepicardium-specific Tbx5 deficiency inhibits expression of
cell adhesion and ECM proteins and delays epicardial cell attachment to the myocardium to disrupt epicardium integrity.
The epicardium defect is made worse by reduced epicardial
cell proliferation. As a result, EPDC production, delamination
into the subepicardial space, and myocardial invasion are impaired. Together, these events contribute to abnormal coronary
vasculogenesis in Tbx5epi-/- embryos. In addition, Tbx5epi-/- mice

exhibit hypoplastic ventricular trabeculation and 15% of mice
display ventricular septal defects consistent with paracrine effects of the epicardium on stimulating myocardial growth and
development. To our knowledge, Tbx5epi-/- mice represent the
first proepicardium-specific deletion mouse model to exhibit
cardiac septation defects. Atrial septal defects caused by apoptosis or reduced cell proliferation were previously observed on
Tbx5 deletion in the endocardium46 or posterior second heart
field,41 respectively. Therefore, it is plausible that EPDCs display similar non cell-autonomous growth-promoting activities
on the interventricular septum. In addition, our analysis of
Wt1 expression in the developing mouse heart documented
the presence of Wt1-positive EPDCs in the interventricular
septum, and reports have raised the possibility that EPDCs
may differentiate into cardiomyocytes in the interventricular
septum.1,8 Thus, septation defects observed in mice with ubiquitous Tbx5 deficiency and in patients with HOS may result
from reduced Tbx5 activity in the myocardium, as well as in
the proepicardium and epicardium.19–21
Proepicardial-specific loss of Tbx5 in mice causes embryonic lethality that may result from cumulative effects on coronary
vasculogenesis and epicardial cell growth and survival to, subsequently, impose myocardial growth defects that alter cardiac
structure. Defective coronary vasculogenesis leads to ischemic
cardiomyopathy in adult Tbx5epi-/- mice. These mice exhibit resting hypoxia and exercise-induced ischemia. It is not uncommon
for human adults to present with poorly explained cardiomyopathy long after childhood repair of congenital heart malformations, and patients with HOS have been reported to develop
diastolic ventricular dysfunction even after repair of septation
defects.47 Ischemia is a well-recognized cause of reduced ventricular compliance, and thus subclinical microvascular hypoplasia in HOS may contribute to chronic ischemia and the late
onset cardiomyopathy that has been observed. On the basis of
our observations that augmentation of chick and murine Tbx5
affects proepicardial development, disrupts epicardial structural
integrity, impairs EPDC development, and decreases vascular
investment of the myocardium, we conclude that Tbx5 is indispensable for normal epicardial and coronary vascular formation
during embryogenesis. This requirement for Tbx5 in mouse and
chick epicardial development may be reflected in the pericardial
agenesis and anomalous coronary arteries seen in human patients with HOS and defective TBX5.19,20 Additional studies will
determine the combined effects of epicardial and myocardial
Tbx5 activity to dissect pathways in normal cardiogenesis and
the phenotypes of patients with HOS.
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Novelty and Significance
What Is Known?
• The proepicardial organ/proepicardium is a grape-like structure located caudal to the heart that contributes precursor cells during cardiovascular development to form the epicardium, pericardium, coronary
vessels, and cardiac fibroblasts through a series of coordinated events
involving regulation of gene expression and cell behavior.
• During cardiovascular development, Tbx5 mRNA is detected in the embryonic chick proepicardial organ, and TBX5 protein is expressed in the
epicardium and coronary vessels of the fetal human heart.
• TBX5 overexpression in the proepicardial organ disrupts proepicardial
cell migration to the coronary vasculature in the embryonic chick heart,
whereas loss of Tbx5 in the developing zebrafish heart leads to the
absence of proepicardium formation.

What New Information Does This Article Contribute?
• We developed strategies to investigate Tbx5 activity in formation and
maturation of the epicardium and coronary vessels through retroviralmediated transgenesis in the embryonic chick and tissue-specific deletion of Tbx5 in the developing mouse proepicardium.
• Our findings reveal that proepicardium -specific loss of mouse Tbx5
causes delayed epicardial attachment to the myocardium and subepicardial accumulation of epicardial-derived cells that, we believe,
precipitates a cascade of events to impair epicardial maturation and
formation of the coronary vasculature, inhibit cardiac growth, and elicit
myocardial hypoxia in the mammalian heart.
• Tbx5 is indispensable for normal epicardial formation and coronary
vasculogenesis during embryogenesis and this may be reflected by the

pericardial agenesis and anomalous coronary arteries seen in some
human patients with Holt–Oram syndrome and TBX5 mutations.

Previous studies identified Tbx5 roles in myocardial, endocardial,
and cardiac conduction system development. However, potential
Tbx5 activity in the epicardium and mammalian coronary vasculogenesis remains unidentified. We show that Tbx5 expression in the
proepicardium and epicardium is heterogeneous. Our augmentation
of Tbx5 expression in embryonic chick proepicardial organ and epicardium reveals its requirement in proepicardial cell migration for
formation and maturation of the epicardium and incorporation of
epicardial-derived cells into coronary blood vessels. Mice genetically engineered for proepicardial-specific Tbx5 loss (Tbx5epi-/-) are born
at sub-Mendelian ratios. Although the proepicardium forms properly
in these mice and proepicardial cells begin migration toward the
myocardium at embryonic day (E)10.5, Tbx5 deficiency delays epicardial cell attachment to the E11.5 myocardium. Cell adhesion and
extracellular matrix gene expression are reduced in E11.5 Tbx5epi-/hearts. Although epicardial cells attach to myocardium by E12.5,
Tbx5epi-/- embryos exhibit other defects, including impaired epicardial-derived cell production and invasion into the myocardium, compromised establishment of coronary vessels, decreased myocardial
growth and myocardial hypoxia. Adult Tbx5epi-/- mice are intolerant
to exercise. We conclude that Tbx5 is required in normal epicardial
formation and coronary vasculogenesis. This requirement provides
insight into pericardial agenesis and anomalous coronary arteries
observed in patients with HOS and TBX5 mutations.
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